About this trial
This study involved two management protocols to manage diabetes in pregnancy. Sixty patients having GDM will be recruited on the basis of the OGTT and randomly allocated to two management groups. One group of patients will receive counselling and the conventional method of management. while the other group will receive a tailored diet plan and physical activity with low caloric and moderate intense exercises. Both groups will receive a dietary plan based on their sugar levels weekly basis and physical activity with pharmacotherapy to adjust their sugar levels, while the intensive group will have rigorous monitoring on a monthly basis and frequent visits with repeated lab checks. This will help us to reduce short and long-term complications with improved maternal and neonatal outcomes.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Maternal age between 18-45 years
Gestational age at enrollment 24 - 28 weeks
Patients having Hba1c levels less then 6%
Disqualifiers
Patients having twin pregnancies
Patients having PCOS
Diabetes diagnosed prior to pregnancy
Patients having severe hypertension
Trial design
Parallel
Treatments tested in this trial
Dietary intervention + Physical Activity + Monitoring
Combination productDietary modifications will follow an 1800-kilocalorie structured plan that includes breakfast, two snacks, lunch, and dinner. The plan will focus on low carbohydrate intake with restrictions on lean options. Adherence will be closely monitored, with a monthly adherence questionnaire (PDAQ) to ensure tight blood sugar control. In terms of physical activity, a structured exercise plan will incorporate household activities, occupational tasks, and various levels of exercise, ranging from light to moderate and intense. Strict monitoring and follow-up will be conducted monthly using the Physical Activity Adherence Questionnaire (PAAQ). Secondly, short acting and long acting insulin dose and frquency will be monitored.
Usual care
Other interventionGeneral advice and recommendations for a low glycemic diet include a flexible and adjusted daily calorie intake, structured meals without a fixed menu. Patients should be educated about healthy choices and empowered to manage their own health. Exercise recommendations should be tailored to the participant's activity level, with routine ANC counseling and no standard follow-up process. If lifestyle modifications are ineffective in controlling glycemic levels, glucophage and human insulin R will be prescribed.
Treatment groups
Trial outcomes
Primary outcomes
Change in HbA1c Levels
HbA1c is measured using high-performance liquid chromatography (HPLC). Values will be compared from baseline to delivery/late pregnancy and postpartum to assess improvement or deterioration in glycemic control.
Physical Activity Level (PAQ)
Physical activity is assessed using the Physical Activity Questionnaire (PAQ), an ordinal scale ranging from 1 to 5. A score ≤2 indicates sedentary activity, while a score ≥3 indicates active physical activity levels. Higher scores reflect greater physical activity engagement.
Secondary outcomes
Fasting or Random Blood Glucose Levels
Blood glucose is measured using the enzymatic glucose oxidase method. A fasting value ≥92 mg/dL is considered abnormal, and a random value ≥200 mg/dL suggests hyperglycemia.
Serum Insulin Levels
Insulin is measured using chemiluminescent immunoassay. A fasting insulin level \>25 μIU/mL indicates hyperinsulinemia.
Serum CMPF
Serum CMPF quantified using ELISA or mass spectrometry. Reported as a continuous variable; higher values indicate increased furan fatty acid levels.
Total Cholesterol
Total cholesterol measured using enzymatic colorimetric assay; interpreted according to pregnancy-adjusted reference ranges.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Khyber Medical University Peshawar
Lead sponsor
Northwest General Hospital and Research centre
Collaborator
Hayatabad Medical Complex
Collaborator